NASDAQ: ACOG

Alpha Cognition Inc. Common Stock

Financial Services | Financial - Conglomerates

No licensed closing price on file for ACOG. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (FY2025)$-1.18

Alpha Cognition Inc. Common Stock (NASDAQ: ACOG) is a financial conglomerate. Figures from SEC EDGAR; updated 2026-10-21 13:40 UTC.

What Alpha Cognition Inc. Common Stock does

The company is a biopharmaceutical firm focused on treating neurodegenerative diseases, particularly Alzheimer's disease. Its lead product, ZUNVEYL, is an oral tablet formulation that received FDA approval and launched commercially in March 2025, targeting long-term care facilities through a specialized sales team. ZUNVEYL is positioned as a next-generation acetylcholinesterase inhibitor with a mechanism that differs from existing treatments by binding to neuronal nicotinic receptors.

Summarized from Alpha Cognition Inc. Common Stock’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation	SCHEDULE 13G 2026-09-23
EPS (FY2025)	$-1.18
Return on equity	-33.06%

Charts

Charts are in the appInteractive charts for ACOG are available in Oxford Ledge.
Open ACOG in Oxford Ledge →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-10-19

2026-10-1910% OwnerPurchase14,283$117.6K
2026-10-1910% OwnerPurchase22,657$191.0K
2026-10-0210% OwnerPurchase19,050$165.6K

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

Opaleye Management Inc.2,895,467$20.91M+13.0%
Solas Capital Management, LLC1,924,617$13.90M0.0%
AWM Investment Company, Inc.1,672,168$12.07M0.0%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2026-06-23Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersRobert WillsEstimatedSEC 8-K →
2026-04-20Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2026-01-15Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersMichael McFaddenEstimatedSEC 8-K →

Company news

View all →

Questions this page answers

What does Alpha Cognition Inc. Common Stock do?

The company is a biopharmaceutical firm focused on treating neurodegenerative diseases, particularly Alzheimer's disease.

When did ACOG last file with the SEC?

Alpha Cognition Inc. Common Stock's most recent SEC filing on record is a SCHEDULE 13G filed 2026-09-23. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-21 13:40 UTC. This page is also available as JSON at /api/data?ticker=ACOG and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ACOG and 5,000+ tickers.

Create a free account — keep ACOG

For your agent

GET /api/data?ticker=ACOG

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt